Z max test for delayed effect in immuno-oncology clinical trials
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Biopharmaceutical Statistics"
DOI: 10.1080/10543406.2019.1632873
Abstract: ABSTRACT Delayed separation in survival curves has been observed in immuno-oncology clinical trials. Under this situation, the classic log-rank test may confront high power loss. In this paper, we consider a Zmax test, which is… read more here.
Keywords: immuno oncology; oncology clinical; clinical trials; zmax test ... See more keywords